KU Leuven and Biocartis to develop diagnostic test for MMR-deficient cancer Dec. 13, 2013 No Comments
FDA grants fast track designation to Navidea Biopharmaceuticals' Lymphoseek Dec. 11, 2013 No Comments
Noninvasive diagnostic agent for early detection of pulmonary hypertension reported Dec. 10, 2013 No Comments
Navidea Biopharmaceuticals begins phase III registration program for NAV-5001 Dec. 4, 2013 No Comments
Navidea to collaborate with UAB on study of RIGS monoclonal antibody targeting agent Dec. 2, 2013 No Comments
Trial shows promising results for SAPPHIRE II eye test designed to identify AD Nov. 26, 2013 No Comments
RSS